Renvela Articles
Impax Labs settles with Genzyme over Renvela and Renagel generics
5 September 2012
Genzyme’s woes continue as it drops investigational APB follow-up for Renvela, after poor trial results
19 November 2009
Third-quarter 2009 profit sinks at Genzyme, on production woes
22 October 2009
Genzyme sues Impax over Renvela patent
7 April 2009
Genzyme's Renvela gets nod for expanded EU label
30 March 2009
Genzyme's 2008 profit down on costs
23 February 2009
Genzyme's 3rd-qtr 2008 profit down 25%
3 November 2008
Genzyme's 2nd qtr profit hit by license cost
4 August 2008
Genzyme's 1st-qtr revenues jump 25%
5 May 2008
Genzyme debuts Renvela for US dialysis patients
10 March 2008
FDA approves Genzyme's Renvela
29 October 2007
Stock Commentary - New York week to July 9, 2007
16 July 2007
Stock Commentary - New York week to June 18, 2007
25 June 2007
Stock Commentary - New York week to June 4, 2007
11 June 2007
Stock Commentary - New York week to Jan 8, 2007
15 January 2007
Genzyme's 1st-qtr sales less than expected
1 May 2006
Showing 1-19 of 19 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
